Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In December: Earnings Summary

TRACON Pharmaceuticals

15/03/2022 21:01

* TRACON Pharmaceuticals Inc  TCON.OQ  reported a quarterly
adjusted loss of 40 cents​​ per share for the quarter ended in
December. The mean expectation of eight analysts for the quarter
was for a loss of 35 cents per share.
    * Reported revenue was zero​;  analysts expected $57.14
thousand. 
    * TRACON Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 40 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * TRACON Pharmaceuticals Inc shares had fallen by 4.0% this
quarter.
    * The company reported a quarterly loss of $7.71 million.
    * Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 15 at 09:00 p.m.  ​All
figures in US dollars unless otherwise stated